In addition to CRP, Mekhail et al. [91] described younger age, male sex, a lower HAQ score and the absence of obesity as positive predictors of treatment response but did not perform a meta-analysis due to high data heterogeneity. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.